OMCL - Omnicell, Inc. Stock Analysis | Stock Taper
Logo

About Omnicell, Inc.

https://www.omnicell.com

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.

Randall A. Lipps

CEO

Randall A. Lipps

Compensation Summary
(Year 2024)

Salary $822,482
Stock Awards $6,009,274
Incentive Plan Pay $1,289,241
All Other Compensation $53,642
Total Compensation $8,174,639
Industry Medical - Healthcare Information Services
Sector Healthcare
Went public August 9, 2001
Method of going public IPO
Full time employees 3,620

ETFs Holding This Stock

Ratings Snapshot

Rating : B+

Discounted Cash Flow 5
Return On Equity 2
Return On Assets 3
Debt To Equity 3
Price To Earnings 1
Price To Book 4
Overall Score 3

Most Recent Analyst Grades

Grade Summary

Buy 1
Overweight 2
Neutral 2

Showing Top 5 of 5

Price Target

Target High $60
Target Low $52
Target Median $55
Target Consensus $55.67

Institutional Ownership

Summary

% Of Shares Owned 93.03%
Total Number Of Holders 355

Showing Top 3 of 355